Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Friedreich ataxia

W G Johnson1

  • 1Department of Neurology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, USA.

Clinical Neuroscience (New York, N.Y.)
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Friedreich ataxia, a genetic disorder causing progressive nervous system damage, is being actively researched. The Friedreich ataxia gene (FRDA) has been localized to chromosome 9, bringing researchers closer to cloning it.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stability of Selected Pesticides on Solid-Phase Extraction Disks.

Journal of environmental quality·2021
Same author

Optics at marshall space flight center.

Applied optics·2010
Same author

Increased excretion of a lipid peroxidation biomarker in autism.

Prostaglandins, leukotrienes, and essential fatty acids·2005
Same author

Validity of test meals for determining binge eating.

Eating behaviors·2004
Same author

The effect of five forage species on transport and transformation of atrazine and isoxaflutole (balance) in lysimeter leachate.

Journal of environmental quality·2003
Same author

Cost-effectiveness studies of medical and chiropractic care for occupational low back pain. a critical review of the literature.

The spine journal : official journal of the North American Spine Society·2003
Same journal

Cardiovascular autonomic dysfunction in parkinsonian patients.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Visuo-cognitive dysfunctions in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Gastrointestinal dysfunction in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Respiratory function in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Neurophysiology of sensorimotor integration in Parkinson's disease.

Clinical neuroscience (New York, N.Y.)·2000
Same journal

Imaging of nonmotor symptoms in Parkinson syndromes.

Clinical neuroscience (New York, N.Y.)·2000
See all related articles

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Friedreich ataxia is an autosomal recessive neurodegenerative disorder.
  • Key clinical features include progressive ataxia, dysarthria, sensory loss, and absent reflexes.
  • Associated conditions include foot deformities, scoliosis, diabetes, and cardiac issues.

Purpose of the Study:

  • To identify the gene responsible for classical Friedreich ataxia.
  • To refine the chromosomal location of the Friedreich ataxia gene (FRDA).
  • To advance understanding of the genetic basis of this ataxia.

Main Methods:

  • Linkage mapping techniques were employed to localize the FRDA gene.
  • Haplotype analysis and analysis of recombinants were used.

Related Experiment Videos

  • Physical mapping, including YAC contig construction, narrowed the gene interval.
  • Mutation analysis is being performed on candidate genes.

    • Main Results:

    • The classical form of Friedreich ataxia was localized to chromosome 9q13-q21.
    • The interval for the FRDA gene was narrowed to a few hundred thousand base pairs.
    • Candidate genes within this region are under investigation.

    Conclusions:

    • The Friedreich ataxia gene (FRDA) is located on chromosome 9.
    • The gene is expected to be cloned soon, facilitating further research.
    • Understanding the FRDA gene will aid in developing diagnostic and therapeutic strategies.